Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption

U E Heidland1, B E Strauer

  • 1Department of Cardiology, Pneumology, and Angiology, School of Internal Medicine, Heinrich-Heine-University, Düsseldorf, Germany. heidland@med.uni-duesseldorf.de

Circulation
|September 26, 2001
PubMed

Insights

Hemodynamic forces, increased left ventricular muscle mass, and higher heart rates are linked to plaque disruption in coronary atherosclerosis. Beta-blocker use was associated with a lower risk of plaque disruption.

Area of Science:

  • Cardiology
  • Cardiovascular Pathophysiology
  • Atherosclerosis Research

Background:

  • Plaque disruption is a key factor in acute coronary syndromes and atherosclerosis progression.
  • Limited information exists regarding factors contributing to plaque disruption.
  • This study investigates the role of hemodynamic forces in plaque disruption pathogenesis.

Purpose of the Study:

  • To analyze the contribution of hemodynamic forces to the pathogenesis of plaque disruption.
  • To identify factors associated with plaque disruption in patients with coronary stenosis.

Main Methods:

  • Retrospective analysis of 106 patients undergoing two coronary angiograms within six months.
  • Comparison of 53 patients with plaque disruption versus 53 controls with stable stenoses.
  • Analysis of central hemodynamics, echocardiographic measurements, and medication use.

Main Results:

  • Logistic regression identified increased left ventricular muscle mass (>270 g) and mean heart rate (>80 bpm) as positively associated with plaque disruption.
  • Use of beta-blockers showed a negative association with plaque disruption.
  • Plaque disruption was diagnosed via coronary angiography in stenosed arteries.

Conclusions:

  • Hemodynamic forces appear to play a significant role in the pathogenesis of plaque disruption.
  • Findings may aid in identifying high-risk patients for plaque disruption.
  • Pharmacological interventions targeting heart rate reduction (e.g., beta-blockers) and left ventricular hypertrophy may be beneficial.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...